GPR119 is expressed in insulin-producing beta cells where it modulates insulin release, thus making it a very attractive therapeutic target for metabolic disorders. GPR119 is activated by oleoylethanolamide (OEA) and by a novel selective small-molecule (PSN632408) which, when administered to high-fat-fed rats, suppresses food intake and reduces body weight gain. Another small molecule full-agonist (AR231453) enhances glucose-dependent insulin release, and improves oral glucose tolerance in wild-type mice, but not in GPR119 knock-out mice.
Product Information | |
---|---|
Catalog #: | ACC-RG0855 |
Gene Name | GPR119 |
Abbr | CHO-HuGPR119 |
Alias | GPR119,GPCR2,hGPCR2,MGC119957 |
Growth Properties | Adherent |
Host Cell | CHO-K1 |
Morphology | Epithelial-like |
Shipping | Dry ice |
Product Type | GPCR Expressing Cell |
Species | Human |
Stability | 12 passages |
Product Format | frozen |
searchKeyword | GPR119,GPCR2,hGPCR2,MGC119957 |
Related Products
Catalog | Product Name | Gene Name | Species | Morphology | Price |
---|---|---|---|---|---|
ACC-RG0244 | Mouse Gpr119-FLAG Stable Cell Line-CHO | Gpr119 | Human | Epithelial-like | INQUIRY |
ACC-RG0243 | Human GPR119-FLAG Stable Cell Line-CHO | GPR119 | Human | Epithelial-like | INQUIRY |
ACC-RG0242 | Human GPR119-FLAG Stable Cell Line-HEK293T | GPR119 | Human | Epithelial | INQUIRY |
Inquiry